Global In-Vitro Toxicity Testing Market Size, Trends & Growth Opportunity, By Type (Absorption, Toxic Substances, Dose), By Technology (Cell Culture Technologies, High Throughput Technologies, Toxicogenomics), By End User (Cosmetics and Households Products, Pharmaceuticals Industry, Food Industry, Chemicals Industry), By Region and forecast till 2027.
Global In-Vitro Toxicity Testing Market
Global In-Vitro Toxicity Testing Market was valued at USD 10.2 billion in 2021 and is anticipated to reach at USD 18.6 billion by 2027 at a CAGR 10.8% from 2022-2027.
In Vitro is the process which used to examine harmful chemicals over the isolated part of the organism. The in-vitro toxicity testing is used to identify hazardous chemical substance and helps to determine toxicity at early-stage evolution of the new products such as drugs, cosmetics, and food additives. The in-vitro toxicity testing is chiefly used for safety assessment in drug development and also for arranging the chemicals according to their potency. The absorption, distribution, metabolism, and elimination (ADME), dose response, and threshold response of the drug can also be detected by in-vitro toxicity testing.
Market Drivers
Opposition to animal testing is anticipated to drive the growth of Global In-Vitro Toxicity Testing during the upcoming years. The rising requirement for in vitro-toxicity testing in various industry such as pharmaceuticals, chemicals and food industry that boost the growth of in-vitro toxicity testing market. Also, increasing in awareness of testing of various cosmetics, foods, and other products, that fuels the growth of the In-Vitro Toxicity Testing Market. The Global In-Vitro Toxicity Testing Market is anticipated to observe noteworthy growth during the forecast period owing to the rise in number of R&D procedures, that need in vitro-testing and growing awareness about the environmental concerns. Additionally, development in genetics and genetic screening approaches and arrival of new approaches of 3D cell culture boost the Global In-Vitro Toxicity Testing Market.
Market Restraints
Questionable predictive power of in-vitro toxicity testing is anticipated to restraint the growth of market. Also, the effect of nanomaterial properties on the result of in vitro toxicity testing through assay interference is anticipated to impede the growth of market.
Market Segmentation
The Global In-Vitro Toxicity Testing Market is segmented into Type, Technology, End User. By Type such as Absorption, Toxic Substances, Dose. By Technology such as Cell Culture Technologies, High Throughput Technologies, Toxicogenomics. By End User such as Cosmetics and Households Products, Pharmaceuticals Industry, Food Industry, Chemicals Industry.
Regional Analysis
The Global In-Vitro Toxicity Testing Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America influences the In-Vitro Toxicity Testing Market and accounted for the largest revenue share of over 4.7% due to raised focus of government bodies for drug discovery, increase in healthcare expenditure, and presence of satisfactory infrastructure for growth and development of drug discovery technologies. Asia Pacific, the market for In-Vitro Toxicity Testing is estimated to register comparatively rapid earn over the next seven 7 years due to development in healthcare infrastructure and increase in government incentives for research in government and private organization.
Key Players
Various Key Players are listed in this report such as Merck KGaA, Charles River, Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific Inc., Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings.
Market Taxonomy
By Technology
- Cell Culture Technologies
- High Throughput Technologies
- Toxicogenomics.
- Absorption
- Toxic Substances
- Dose
- Cosmetics and Households Products
- Pharmaceuticals Industry
- Food Industry
- Chemicals Industry.
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa.
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global In-Vitro Toxicity Testing Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global In-Vitro Toxicity Testing Market, By Technology
- 5.1 Y-o-Y Growth Comparison, By Type
- 5.2 Global In-Vitro Toxicity Testing Market Share Analysis, By Technology
- 5.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By Technology
- 5.3.1 Cell Culture Technologies
- 5.3.2 High Throughput Technologies
- 5.3.3 Toxicogenomics.
- 6 Global In-Vitro Toxicity Testing Market, By Type
- 6.1 Y-o-Y Growth Comparison, By Type
- 6.2 Global In-Vitro Toxicity Testing Market Share Analysis, By Type
- 6.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By Type
- 6.3.1 Absorption
- 6.3.2 Toxic Substances
- 6.3.3 Dose
- 7 Global In-Vitro Toxicity Testing Market, By End-user
- 7.1 Y-o-Y Growth Comparison, By End-user
- 7.2 Global In-Vitro Toxicity Testing Market Share Analysis, By End-user
- 7.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By End-user
- 7.3.1 Cosmetics and Households Products
- 7.3.2 Pharmaceuticals Industry
- 7.3.3 Food Industry
- 7.3.4 Chemicals Industry.
- 8 Global In-Vitro Toxicity Testing Market, By Region
- 8.1 Global In-Vitro Toxicity Testing Market Share Analysis, By Region
- 8.2 Global In-Vitro Toxicity Testing Market Share Analysis, By Region
- 8.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By Region
- 9 North America In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
- 9.1 Introduction
- 9.2 North America In-Vitro Toxicity Testing Market Share Analysis, By Type
- 9.3 North America In-Vitro Toxicity Testing Market Size and Forecast, By Technology
- 9.4 North America In-Vitro Toxicity Testing Market Size and Forecast, By End-use
- 9.6 North America In-Vitro Toxicity Testing Market Size and Forecast, By Country
- 9.7.1 U.S.
- 9.7.2 Canada
- 9.7.3 Mexico
- 10 Europe In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
- 10.1 Introduction
- 10.2 Europe In-Vitro Toxicity Testing Market Share Analysis, By Type
- 10.3 Europe In-Vitro Toxicity Testing Market Size and Forecast, By Technology
- 10.4 Europe In-Vitro Toxicity Testing Market Size and Forecast, By End-user
- 10.5 Europe In-Vitro Toxicity Testing Market Size and Forecast, By Country
- 10.5.1 Germany
- 10.5.2 France
- 10.5.3 UK
- 10.5.4. Rest of Europe
- 11 Asia Pacific In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
- 11.1 Introduction
- 11.2 Asia Pacific In-Vitro Toxicity Testing Market Share Analysis, By Type
- 11.3 Asia Pacific In-Vitro Toxicity Testing Market Size and Forecast, By Technology
- 11.4 Asia Pacific In-Vitro Toxicity Testing Market Size and Forecast, By End-user
- 11.5 Asia Pacific In-Vitro Toxicity Testing Market Size and Forecast, By Country
- 11.5.1 China
- 11.5.2 Japan
- 11.5.3 India
- 11.5.4. Rest of Asia Pacific
- 12 Latin America In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
- 12.1 Introduction
- 12.2 Latin America In-Vitro Toxicity Testing Market Share Analysis, By Type
- 12.3 Latin America In-Vitro Toxicity Testing Market Size and Forecast, By Technology
- 12.4 Latin America In-Vitro Toxicity Testing Market Size and Forecast, By End-user
- 12.5 Latin America In-Vitro Toxicity Testing Market Size and Forecast, Country
- 12.5.1. Brazil
- 12.5.2. Rest of Latin America
- 13 Middle East In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
- 13.1 Introduction
- 13.2 Middle East In-Vitro Toxicity Testing Market Share Analysis, By Type
- 13.3 Middle East In-Vitro Toxicity Testing Market Size and Forecast, By Technology
- 13.4 Middle East In-Vitro Toxicity Testing Market Size and Forecast, By End-user
- 13.5 Middle East In-Vitro Toxicity Testing Market Size and Forecast, By Country
- 13.5.1. Saudi Arabia
- 13.5.2. UAE
- 13.5.3. Egypt
- 13.5.4. Kuwait
- 13.5.5. South Africa
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Merck KGaA
- 15.1.1 Overview
- 15.1.2 Products
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2 Charles River
- 15.2.1 Overview
- 15.2.2 Products
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3 Bio-Rad Laboratories, Inc.
- 15.3.1 Overview
- 15.3.2 Products
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 Abbott
- 15.4.1 Overview
- 15.4.2 Products
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Thermo Fisher Scientific Inc
- 15.5.1 Overview
- 15.5.2 Products
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Catalent, Inc.
- 15.6.1 Overview
- 15.6.2 Products
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 GE Healthcare
- 15.7.1 Overview
- 15.7.2 Products
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 Quest Diagnostics Incorporated
- 15.8.1 Overview
- 15.8.2 Products
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
- 15.9 Eurofins Scientific
- 15.9.1 Overview
- 15.9.2 Products
- 15.9.3 Key Financials
- 15.9.4 Business Segment & Geographic Overview
- 15.9.5 Key Market Developments
- 15.9.6 Key Strategies
- 15.10 Laboratory Corporation of America Holdings
- 15.10.1 Overview
- 15.10.2 Products
- 15.10.3 Key Financials
- 15.10.4 Business Segment & Geographic Overview
- 15.10.5 Key Market Developments
- 15.10.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook